InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on “Global Coronavirus Vaccine Market– By Trends, Clinical Trial/Pipeline Analysis, Industry Competition Analysis, Revenue and Forecast Till 2030”
According to the latest research by InsightAce Analytic, the global coronavirus vaccine market size valued at US$ XX Million and it is expected to reach US$ XX Million in 2030, recording a promising CAGR of XX% during the period of 2020-2030. By region, North America dominates the market with share of XX% of global coronavirus vaccine market.
COVID-19 virus causes respiratory illness in humans. It may cause serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is the one which can cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS). To combat with COVID-19, WHO has procured and distributed oxygen supplies for vulnerable countries. By December 2020, WHO had sent more than 16 500 oxygen concentrators and 40 000 pulse oximeters and oxygen monitors to 121 countries. Increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in expansion of coronavirus vaccine market over the forecast period. Currently, to check the safety and effectiveness of COVID-19 vaccines, many vaccines are going through the processes of clinical trials and validations.
Major factors responsible for the growth of this market are fast adoption of advance technologies, growing number of corona patients, increasing healthcare expenditures, rising awareness about corona virus, and increasing efforts by the pharmaceutical companies for the development of covid-19 vaccines. Furthermore, increasing research investments for the R&D of covid-19 vaccines is anticipated to drive the market growth in future. For instance, on 18 February 2020, Sanofi Pasteur, a vaccines global business unit of Sanofi S.A. announced to collaborate with Biomedical Advanced Research and Development Authority (BARDA), for the development of its novel coronavirus vaccine candidate, which has been developed using the recombinant DNA platform. However, high cost required for clinical trials and for validation of vaccines is restraining the growth of coronavirus vaccine market.
During the forecast period 2020-2030, North America is expected to dominate the coronavirus vaccine market, owing to advancement of technologies, growing awareness about corona virus, rising government initiatives for R&D of covid-19 vaccines, and increasing number of market players in this region. On the other hand, Europe region will also hold the largest share of this market during the forecast years, due to rising government initiatives in R&D and increasing demand for covid-19 vaccines. Furthermore, Asia Pacific is estimated to be the fastest-growing regional market in the future, attributed to increasing number of corona patients, rising awareness about corona virus, and entry of new players in the market.
Some of the major key Players of coronavirus vaccine market are I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna, AstraZeneca, Pfizer, Johnson &Johnson, GlaxoSmithKline, Bharath Biotech, Serum Institute of India, Sinopharm, AnGes, AIVITABiomedical, CanSinoBio, eubiologics, Genexine, GreenLight Bioscience, Gennova, Heat Biologics, INOVIO, IIBR, medicago, Symvivo, Valneva, Zydus Cadila, and Other Prominent Players. Prominent players are focusing on various strategies like novel product launches, partnerships, merges, agreements, acquisitions, and many others to increase their demand in this market.
On 08 April 2020, Novavax, Inc., announced that it has identified a coronavirus vaccine candidate, NVX-CoV2373 and will initiate a first-in-human trial in mid-May of 2020. And on 07 August 2020, Novavax, Inc. entered into a partnership with Takeda Pharmaceutical Company Limited for the development, manufacturing and commercialization of NVX‑CoV2373, a COVID‑19 vaccine candidate of Novavax, in Japan.
In March 2020, Pfizer and BioNTech announced strategic collaboration to advance development in mRNA vaccine for coronavirus infection. This will fasten development process and offer competitive advantage to the company.
Curious about this latest version of report? Obtain Report Details @https://www.insightaceanalytic.com/report-details/global-coronavirus-vaccine-market/#request-for-tocproposal
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Infection Type
- New Haven CoV
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Vaccine Type
- Inactivated coronavirus vaccine
- Live attenuated coronavirus vaccine
- S-Protein based coronavirus vaccine
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on End-Users
- Research Institutes
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
North America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
Europe coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
- Rest of Europe
Asia Pacific coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
- South Korea
- Australia & New Zealand
Latin America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
- Rest of Latin America
Middle East & Africa coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global coronavirus vaccine market
- To receive industry overview and future trends of coronavirus vaccine market
- To analyze the coronavirus vaccine market drivers and challenges
- To get information on coronavirus vaccine market size value (US$ Mn) forecast till 2030
- Major Investments, Mergers & Acquisition in coronavirus vaccine market industry
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ